ARTICLES BY ANNA ROSE WELCH
-
Defining The RNA Therapeutics Industry In 20231/16/2023
Four executives outline which industry challenges, strategic considerations, and opportunities should be top of mind as RNA therapeutics companies establish their to-do lists for 2023.
-
mRNA & RNA Therapeutics In 2023: Where Do We Go From Here?12/7/2022
To figure out what the future holds for companies in the RNA sector of the ATMP space, I sat down with four executives to discuss their wildest hopes, dreams, and expectations. As you’ll note, there is no shortage of work facing the RNA therapeutics industry in the year(s) ahead. But there’s also a lot for which we can hope.
This website uses cookies to ensure you get the best experience on our website. Learn more